As with the four top biotechnology clusters profiled by GEN earlier this month, the next five largest life science focused states face long-term challenges of finding financing for start-ups and managing the growth that they expect over the next several years.
Bioclusters in Colorado, Florida, New Jersey, Pennsylvania, and Washington are also likely to see state governments more constrained in their ability to help as they had in past years; large budget deficits are forcing them to cut spending. These states are thus trying to revamp their respective industry growth strategies.
To read the full, original article click on this link: GEN | Analysis & Insight: Review of the Second Tier of Biotechnology Clusters in the U.S.
Author: Alex Philippidis
